Ossiam Acquires Shares of 165,429 Astera Labs, Inc. $ALAB

Ossiam bought a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB) in the third quarter, Holdings Channel.com reports. The firm bought 165,429 shares of the company’s stock, valued at approximately $32,391,000.

Other large investors have also recently modified their holdings of the company. Assetmark Inc. raised its position in shares of Astera Labs by 374.1% in the third quarter. Assetmark Inc. now owns 128 shares of the company’s stock valued at $25,000 after purchasing an additional 101 shares during the period. Pinpoint Asset Management Singapore Pte. Ltd. bought a new position in Astera Labs in the 3rd quarter worth approximately $47,000. Whittier Trust Co. bought a new position in Astera Labs in the 3rd quarter worth approximately $55,000. Ramirez Asset Management Inc. purchased a new position in Astera Labs in the 3rd quarter valued at approximately $59,000. Finally, Atlantic Union Bankshares Corp grew its stake in Astera Labs by 1,338.1% in the 3rd quarter. Atlantic Union Bankshares Corp now owns 302 shares of the company’s stock valued at $59,000 after buying an additional 281 shares in the last quarter. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Wall Street Analysts Forecast Growth

ALAB has been the topic of several recent research reports. Loop Capital initiated coverage on Astera Labs in a research report on Thursday, March 5th. They set a “buy” rating and a $250.00 target price on the stock. Northland Securities lifted their price target on Astera Labs from $175.00 to $195.00 and gave the company an “outperform” rating in a research report on Tuesday, December 9th. Barclays set a $165.00 price objective on Astera Labs in a research note on Thursday, January 15th. Royal Bank Of Canada initiated coverage on Astera Labs in a research note on Wednesday, January 14th. They issued an “outperform” rating and a $225.00 target price for the company. Finally, Weiss Ratings lowered Astera Labs from a “hold (c-)” rating to a “sell (d+)” rating in a report on Monday, February 23rd. Fifteen research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, Astera Labs presently has a consensus rating of “Moderate Buy” and a consensus target price of $202.22.

Insider Activity at Astera Labs

In related news, COO Sanjay Gajendra sold 94,971 shares of the firm’s stock in a transaction that occurred on Tuesday, February 17th. The shares were sold at an average price of $123.81, for a total value of $11,758,359.51. Following the sale, the chief operating officer directly owned 1,531,301 shares of the company’s stock, valued at $189,590,376.81. This trade represents a 5.84% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Jack R. Lazar sold 7,500 shares of Astera Labs stock in a transaction that occurred on Thursday, March 5th. The shares were sold at an average price of $119.80, for a total transaction of $898,500.00. Following the sale, the director owned 87,351 shares of the company’s stock, valued at approximately $10,464,649.80. The trade was a 7.91% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 224,292 shares of company stock valued at $27,676,069 in the last ninety days. Insiders own 12.50% of the company’s stock.

Astera Labs Stock Performance

Shares of ALAB stock opened at $120.31 on Friday. The company has a market capitalization of $20.48 billion, a PE ratio of 98.61, a price-to-earnings-growth ratio of 2.36 and a beta of 1.74. Astera Labs, Inc. has a 52-week low of $47.13 and a 52-week high of $262.90. The business’s fifty day moving average is $147.89 and its 200 day moving average is $168.18.

Astera Labs (NASDAQ:ALAB) last posted its earnings results on Tuesday, February 10th. The company reported $0.58 EPS for the quarter, topping the consensus estimate of $0.51 by $0.07. The business had revenue of $270.58 million during the quarter, compared to analysts’ expectations of $249.46 million. Astera Labs had a return on equity of 16.12% and a net margin of 25.70%.The firm’s revenue was up 91.8% on a year-over-year basis. During the same period in the previous year, the business earned $0.37 earnings per share. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. On average, sell-side analysts forecast that Astera Labs, Inc. will post 0.34 EPS for the current fiscal year.

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.